Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Vivoryon Therapeutics N.V. | 1 | 0 | 0 | 0 | €0.66 | - | - |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.94 | €8.39 | 332.613% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.45 | €65.00 | -2.182% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €1.88 | €12.09 | 543.053% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €141.15 | €165.00 | 16.897% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 1 | 0 | €49.65 | €57.50 | 15.811% |
| Stratec SE | 2 | 0 | 0 | 0 | €43.50 | - | - |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.90 | €10.00 | 156.410% |
| ProQR Therapeutics N.V. | 6 | 0 | 1 | 0 | €1.89 | €2.81 | 48.695% |
| R1 RCM Inc. | 19 | 0 | 2 | 0 | €11.40 | €17.21 | 50.988% |
| Poxel S.A. | 1 | 0 | 0 | 0 | €0.67 | €0.70 | 4.322% |
| iRhythm Technologies Inc | 10 | 0 | 0 | 0 | €104.00 | €122.84 | 18.114% |
| Pro-Dex Inc. | 16 | 0 | 0 | 0 | €16.90 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €69.60 | €100.00 | 43.678% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €36.60 | €46.08 | 25.908% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.01 | €23.46 | 67.480% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €200.30 | €204.50 | 2.097% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €39.57 | €48.50 | 22.568% |
| Trinity Biotech ADR | 23 | 0 | 2 | 0 | €0.41 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.48 | €4.00 | 61.290% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
| CareRx Corp. | 1 | 0 | 0 | 0 | €1.60 | €2.00 | 25.000% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.64 | €4.39 | 168.253% |